US Patent 11014965 Modulation of complement activity
Patent 11014965 was granted and assigned to Ra Pharmaceuticals on May, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 2, 2020
Date of Patent
May 25, 2021
Patent Applicant
Patent Application Number
16732502
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11014965 Modulation of complement activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
